Recruiting

Observational Study

Sponsor:

Texas Woman's University

Code:

NCT06313359

Conditions

Peripheral Neuropathy Due to Chemotherapy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Study Details

Brief summary:

The purpose of this research is to examine the impact of peripheral neuropathy on fall risk and quality of life in people who had cancer and neuropathy from cancer treatments. The investigators are interested to find out if the participant have any difficulty with thinking, feeling, balancing, or moving around that will contribute to risk for falls or quality of life. Investigators are also interested to see if the participants have any difficulty with doing two activities at the same time, such as walking and texting.

Conditions

Peripheral Neuropathy Due to Chemotherapy

Study ID

NCT06313359

Start date

Mar 30, 2024

Status verified date

Oct, 2024

Completion date

Jun 30, 2026

Anticipated

Primary completion date

Dec 30, 2025

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

Experimental group

  • Individuals 18 years and older
  • diagnosed with non- CNS cancer who underwent treatment and presents with peripheral neuropathy symptoms.

Control group

  • age (+/- one year) and gender matched individuals
  • no diagnosed peripheral neuropathy
  • No diagnosed cognitive symptoms.

Exclusion Criteria:

  • Unable to follow two step commands.
  • Unable to ambulate x 50 feet independently without use of an assistive device.
  • Unable to use a phone to send text messages.
  • Diagnosis of diabetic peripheral neuropathy
  • Diagnosis of CNS cancer.
  • Unable to speak/understand English

Study Design

Enrollment

40 participants

Anticipated

Interventions and Outcome Measures

Arms

Cancer treatment induced peripheral neuropathy

Individuals with a history of non CNS cancer with cancer treatment induced peripheral neuropathy symptoms.

Control group

Age and gender matched individuals without peripheral neuropathy symptoms.

Primary outcome measure

  • Fall risk [ Time Frame: 5 minutes ]
  • Quality of life- in cancer patients [ Time Frame: 5 minutes ]

Central Contacts and Locations

Central contacts

Priya Karakkattil

12148625624Pkarakkattil@twu.edu

Locations

Texas Woman's University

Recruiting

Dallas, Texas, United States, 75235

Contacts

Priya Karakkattil, PhD

214-689-7726Pkarakkattil@twu.edu

More Information

Sponsor

Texas Woman's University

Last update posted

Sep 3, 2025

Last verified

Oct, 2024

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-19. This information was provided to ClinicalTrials.gov by Texas Woman's University on 2025-09-03.